The objective of this investigation is to elucidate the mechanistic evidence substantiating the correlation between ASPA and PCa progression, as well as to assess the potential of ASPA as a viable therapeutic target for the management of PCa. The gene discussed is ASPA; the disease is posterior cortical atrophy.